Use of capnography and transcutaneous oxygen monitoring during outpatient general anesthesia for oral surgery

1987 ◽  
Vol 45 (1) ◽  
pp. 3-10 ◽  
Author(s):  
Jay A. Anderson ◽  
Phyllis J. Clark ◽  
Enid R. Kafer
1990 ◽  
Vol 57 (1) ◽  
pp. 47-52
Author(s):  
Sikander Adeni ◽  
D. Vidyasagar

1944 ◽  
Vol 5 (3) ◽  
pp. 321-322
Author(s):  
J. G. ARROWOOD

2018 ◽  
Vol 10 (48) ◽  
pp. 41026-41034 ◽  
Author(s):  
Chang-Jin Lim ◽  
Soyeon Lee ◽  
Jin-Hoon Kim ◽  
Hye-Jun Kil ◽  
Yu-Chan Kim ◽  
...  

1984 ◽  
Vol 12 (2) ◽  
pp. 121-124 ◽  
Author(s):  
HOWARD W. KILBRIDE ◽  
GERALD B. MERENSTEIN

1983 ◽  
Vol 5 (1) ◽  
pp. 5-12
Author(s):  
Marykay Pasnick ◽  
Jerold F. Lucey

The comparison between intermittent Pao2 samples and a continuous transcutaneous PO2 recording can be compared to viewing a sports event by means of a single black and white photograph taken during the game versus a televised version complete with instant replays. Transcutaneous monitoring has made it possible to visualize the immediate effect of therapeutic maneuvers on PO2 as well as the physiologic response to a variety of routine procedures. In certain clinical situations with circulatory compromise, this measurement of tissue oxygenation may be a more pertinent clinical parameter than Pao2. The ability to monitor transcutaneous O2 tension continuously should enable researchers to further unravel the relationship of Po2 to various neonatal disorders such as retinopathy of prematurity, bronchopulmonary dysplasia, and intraventricular hemorrhage. Other physiologic parameters may also be measured transcutaneously. A transcutaneous Pco2 monitor is now in use clinically, and a transcutaneous pH electrode, still in the developmental process, should be available in the near future. Like the transcutaneous Po2 monitor, these devices generate a continuous flow of clinical data enabling nurses and physicians to make rapid informed decisions based on the patient's current physiologic status.


2018 ◽  
Vol 65 (3) ◽  
pp. 168-176 ◽  
Author(s):  
Shu Tomita ◽  
Shinya Yamazaki ◽  
Kohei Togami ◽  
Hitoshi Tada ◽  
Hiroyoshi Kawaai

Dexmedetomidine (DEX) is a sedative and analgesic agent that acts via the alpha-2 adrenoreceptor and is associated with reduced anesthetic requirements, as well as attenuated blood pressure and heart rate in response to stressful events. A previous study reported that cat gingival blood flow was controlled via sympathetic alpha-adrenergic fibers involved in vasoconstriction. In the present study, experiment 1 focused on the relationship between the effects of DEX on alpha adrenoreceptors and vasoconstriction in the tissues of the oral cavity and compared the palatal mucosal blood flow (PMBF) in rabbits between general anesthesia with sevoflurane and sedation with DEX. We found that the PMBF was decreased by DEX presumably because of the vasoconstriction of oral mucosal vessels following alpha-2 adrenoreceptor stimulation by DEX. To assess if this vasoconstriction would allow decreased use of locally administered epinephrine during DEX infusion, experiment 2 in the present study monitored the serum lidocaine concentration in rabbits to compare the absorption of lidocaine without epinephrine during general anesthesia with sevoflurane and sedation with DEX. The depression of PMBF by DEX did not affect the absorption of lidocaine. We hypothesize that this is because lidocaine dilates the blood vessels, counteracting the effects of DEX. In conclusion, despite decreased palatal blood flow with DEX infusion, local anesthetics with vasoconstrictors should be used in implant and oral surgery even with administered DEX.


1983 ◽  
Vol 22 (6) ◽  
pp. 431-435 ◽  
Author(s):  
William C. L. Yip ◽  
John S. H. Tay ◽  
H.B. Wong ◽  
T.F. Ho

Sign in / Sign up

Export Citation Format

Share Document